Overview

Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of multiple doses of ketoconazole on the pharmacokinetics of a single dose of BAY73-4506 in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Ketoconazole